Business

Pearl Therapeutics has raised $65 million from current investors to enable initiation of Phase 3 trials for its PT003 glycopyrrolate (GP)/formoterol fumarate (FF) MDI for the treatment of COPD, the company says. This round of financing brings the total to $167.5 million since 2007. Pearl CEO Chuck Bramlage said, “Through our comprehensive Phase 2 program, Pearl … [Read more...] about Pearl Therapeutics gets funding for Phase 3 studies of PT003

Boehringer Ingelheim has announced an €85 million expansion to the BI microParts GmbH inhaler manufacturing facililty in Dortmund, Germany meant to double its annual production of Respimat inhalers to 44 million by 2015. Filling of the Respimat inhalers takes place in Ingelheim. The company says that it will need to add more than 100 new hires to the existing 450 … [Read more...] about Boehringer Ingelheim to double production at Respimat facility

According to the Associated Press, GlaxoSmithKline is extending its "Complete the Cycle" inhaler recycling program to 31 US cities, which were chosen because they account for about a third of all inhaler sales in the US, the company said. Patients will be able to drop off used inhalers at approximately 2,000 pharmacies in those cities. A statement about inhaler … [Read more...] about GSK launches inhaler recycling program in US

On October 17, MannKind Corporation announced a plan to sell 40,000,000 shares of its common stock, plus warrants to purchase up to 30,000,000 shares, in a public offering, which it said may or may not be completed. Each share is being sold with a warrant, for a total price of $2.00/share. The funds raised will be used for on-going trials of Afrezza inhaled insulin. … [Read more...] about MannKind announces public stock offering

Market research firm Frost & Sullivan is presenting its 2012 Global Enabling Technology Award to Alexza Pharmaceuticals for its Staccato thermal vaporization inhaler platform. The award is designed to recognize a company for "developing a technology that enables the creation of new products and applications and/or enhances current products" along with the "potential … [Read more...] about Alexza gets Global Enabling Technology Award from Frost & Sullivan

Contract manufacturer PharmaForm, a subsidiary of Akela Pharma, has announced plans to move from Austin, TX to the San Diego, CA area. The company offers formulation and manufacturing services for numerous dosage forms, including nasal sprays and inhalation powders. PharmaForm President and CEO Rudy J. Emmelot commented, "We are excited about our move to San Diego … [Read more...] about PharmaForm moving to San Diego

The United States' National Aeronautics and Space Administration (NASA) has signed a development and commercialization agreement with Epiomed Therapeutics for intranasal scopolamine. The nasal spray for the treatment of motion sickness is also called INSCOP. According to NASA, it has collected extensive data on motion sickness from the experience of astronauts in … [Read more...] about NASA and Epiomed in deal to develop intranasal scopolamine